Erythritol and xylitol differentially impact brain networks involved in appetite regulation in healthy volunteers.

Anne Christin Meyer-Gerspach, Jed O Wingrove, Christoph Beglinger, Jens F Rehfeld, Carel W Le Roux, Ralph Peterli, Patrick Dupont, Owen O'Daly, Lukas Van Oudenhove, Bettina K Wölnerhanssen

Journal: Nutritional neuroscience 2022;25(11):2344-2358

PMID: 34404339

Abstract

BACKGROUND

There is a growing consensus that sugar consumption should be reduced and the naturally occurring, low-calorie sweeteners xylitol and erythritol are gaining popularity as substitutes, but their effect on brain circuitry regulating appetite is unknown.

AIM

The study's objective was to examine the effects of the two sweeteners on cerebral blood flow (rCBF) and resting functional connectivity in brain networks involved in appetite regulation, and test whether these effects are related to gut hormone release.

METHODS

The study was performed as a randomized, double-blind, placebo-controlled, cross-over trial. Twenty volunteers received intragastric (ig) loads of 50g xylitol, 75g erythritol, 75g glucose dissolved in 300mL tap water or 300mL tap water. Resting perfusion and blood oxygenation level-dependent data were acquired to assess rCBF and functional connectivity. Blood samples were collected for determination of CCK, PYY, insulin and glucose.

RESULTS

We found: (i) xylitol, but not erythritol, increased rCBF in the hypothalamus, whereas glucose had the opposite effect; (ii) graph analysis of resting functional connectivity revealed a complex pattern of similarities and differences in brain network properties following xylitol, erythritol, and glucose; (iii) erythritol and xylitol induced a rise in CCK and PYY, (iv) erythritol had no and xylitol only minimal effects on glucose and insulin.

CONCLUSION

Xylitol and erythritol have a unique combination of properties: no calories, virtually no effect on glucose and insulin while promoting the release of gut hormones, and impacting appetite-regulating neurocircuitry consisting of both similarities and differences with glucose.

Address: St. Clara Research Ltd at St. Clara Hospital, Basel, Switzerland.; Department of Medicine, University of Basel, Basel, Switzerland.; Centre for Obesity Research, University College London, London, UK.; St. Clara Research Ltd at St. Clara Hospital, Basel, Switzerland.; Department of Clinical Biochemistry, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.; Diabetes Complications Research Centre, Conway Institute University College Dublin, Dublin, Ireland.; Department of Medicine, University of Basel, Basel, Switzerland.; Clarunis, Department of Visceral Surgery, University Centre for Gastrointestinal and Liver Diseases, St. Clara Hospital and University Hospital Basel, Basel, Switzerland.; Department of Neurosciences, Laboratory for Cognitive Neurology, KU Leuven, Leuven, Belgium.; Centre for Neuroimaging Sciences, King's College London's Institute of Psychiatry, Psychology and Neuroscience, London, UK.; Laboratory for Brain-Gut Axis Studies (LaBGAS), Translational Research Center for Gastrointestinal Disorders (TARGID), Department of Chronic Diseases, Metabolism & Ageing, KU Leuven, Leuven, Belgium.; Cognitive and Affective Neuroscience Lab (CANlab), Department of Psychological & Brain Sciences, Dartmouth College, Hanover, NH, USA.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.